Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$1.16 - $2.23 $32,498 - $62,475
-28,016 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$2.24 - $4.29 $23,157 - $44,350
10,338 Added 58.48%
28,016 $64,000
Q2 2021

Aug 02, 2021

BUY
$4.39 - $7.23 $77,606 - $127,811
17,678 New
17,678 $52,000
Q1 2021

Apr 28, 2021

SELL
$4.39 - $9.08 $60,836 - $125,830
-13,858 Closed
0 $0
Q4 2020

Jan 27, 2021

BUY
$3.86 - $5.07 $53,491 - $70,260
13,858 New
13,858 $82,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.